Cetera Investment Advisers
ABVX

Cetera Investment Advisers’s Abivax ABVX Stock Holding History

Cetera Investment Advisers’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
8,114
+854
+12% +$96.7K ﹤0.01% 2987
2026
Q1 		$808K Buy
7,260
+552
+8% +$65.3K ﹤0.01% 3095
2025
Q4 		$905K Buy
+6,708
New +$732K ﹤0.01% 2904

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Investment Advisers's ABVX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Abivax (ABVX) stake by 12% in Q2 2026, buying an estimated $96.7K and bringing the position to 8,114 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

Cetera Investment Advisers first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Cetera Investment Advisers held 8,114 shares of Abivax worth $1.08M as of Q2 2026.
  • Cetera Investment Advisers bought 854 Abivax shares in Q2 2026, an estimated $96.7K.
  • Abivax made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2987 holding.
  • Cetera Investment Advisers first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.